Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe… - Therapeutic …, 2020 - journals.sagepub.com
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe… - … in Endocrinology and …, 2020 - cir.nii.ac.jp
抄録< jats: p> Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome
with high mortality for which there is no proven therapy to improve its prognosis. Thyroid …
with high mortality for which there is no proven therapy to improve its prognosis. Thyroid …
[HTML][HTML] Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe… - … in Endocrinology and …, 2020 - ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
[PDF][PDF] Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe, M Borges-Canha… - 2020 - pdfs.semanticscholar.org
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction.
JS Neves, C Vale, M von Hafe… - … in Endocrinology and …, 2020 - europepmc.org
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe… - Therapeutic …, 2020 - pubmed.ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
[PDF][PDF] Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
JS Neves, C Vale, M von Hafe, M Borges-Canha… - 2020 - researchgate.net
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with high
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …
mortality for which there is no proven therapy to improve its prognosis. Thyroid dysfunction is …